MX3550A - Procedimiento para preparar derivados de metilendiocxifenantreno y estilbeno. - Google Patents

Procedimiento para preparar derivados de metilendiocxifenantreno y estilbeno.

Info

Publication number
MX3550A
MX3550A MX355086A MX355086A MX3550A MX 3550 A MX3550 A MX 3550A MX 355086 A MX355086 A MX 355086A MX 355086 A MX355086 A MX 355086A MX 3550 A MX3550 A MX 3550A
Authority
MX
Mexico
Prior art keywords
methylendiocxifenantrene
stylbene
procedure
preparing derivatives
derivatives
Prior art date
Application number
MX355086A
Other languages
English (en)
Other versions
MX172917B (es
Inventor
Klaus Gorler
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of MX3550A publication Critical patent/MX3550A/es
Publication of MX172917B publication Critical patent/MX172917B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX003550A 1985-08-28 1986-08-26 Procedimiento para preparar compuestos de metilendioxifenantreno y producto obtenido MX172917B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853530718 DE3530718A1 (de) 1985-08-28 1985-08-28 Methylendioxyphenanthren- und -stilbenderivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten

Publications (2)

Publication Number Publication Date
MX3550A true MX3550A (es) 1993-10-01
MX172917B MX172917B (es) 1994-01-21

Family

ID=6279566

Family Applications (2)

Application Number Title Priority Date Filing Date
MX003550A MX172917B (es) 1985-08-28 1986-08-26 Procedimiento para preparar compuestos de metilendioxifenantreno y producto obtenido
MX9300436A MX9300436A (es) 1985-08-28 1993-01-27 Composicion farmaceutica para estimular el sistema inmune.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX9300436A MX9300436A (es) 1985-08-28 1993-01-27 Composicion farmaceutica para estimular el sistema inmune.

Country Status (27)

Country Link
US (2) US4835178A (es)
JP (1) JPS62167776A (es)
KR (1) KR880000179B1 (es)
AR (1) AR242568A1 (es)
AT (1) AT398568B (es)
BE (1) BE905340A (es)
CH (1) CH673457A5 (es)
DD (1) DD266800A5 (es)
DE (1) DE3530718A1 (es)
DK (1) DK168705B1 (es)
ES (1) ES2001893A6 (es)
FI (1) FI92396C (es)
FR (1) FR2586681B1 (es)
GB (1) GB2179347B (es)
HU (3) HU199446B (es)
IE (1) IE59239B1 (es)
IT (1) IT1197467B (es)
LU (1) LU86556A1 (es)
MX (2) MX172917B (es)
NL (1) NL8602127A (es)
NO (1) NO863434L (es)
PL (2) PL154026B1 (es)
PT (1) PT83258B (es)
SE (1) SE465153B (es)
SU (1) SU1731053A3 (es)
YU (2) YU44061B (es)
ZA (1) ZA866487B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038573T1 (es) * 1989-12-15 1993-08-01 Pharma Mar, S.A. Nuevos compuestos del tipo diterpeno.
EP0498095B1 (en) * 1991-02-05 1995-01-04 Merrell Dow Pharmaceuticals Inc. Sulfonic stilbene derivatives in the treatment of viral diseases
EP0626945B1 (en) * 1992-02-20 1998-04-22 Merrell Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
US5334615A (en) * 1992-12-17 1994-08-02 Walles Wilhelm E Oil with bactericidal and virucidal properties
US5739166A (en) * 1994-11-29 1998-04-14 G.D. Searle & Co. Substituted terphenyl compounds for the treatment of inflammation
CN112778264B (zh) * 2021-01-21 2023-09-15 江西农业大学 马兜铃次酸衍生物及其在制备抗炎药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
JPS57106677A (en) * 1980-12-22 1982-07-02 Kureha Chem Ind Co Ltd N-(3,4-methylenedioxybenzylidene) aminomethylcyclohexane-carboxylic acid, and salt of said carboxylic acid

Also Published As

Publication number Publication date
HU202104B (en) 1991-02-28
FI92396C (fi) 1994-11-10
ATA215186A (de) 1994-05-15
PT83258B (pt) 1988-07-01
ES2001893A6 (es) 1988-07-01
HU199446B (en) 1990-02-28
DK407586A (da) 1987-03-01
FI863282A (fi) 1987-03-01
US4835178A (en) 1989-05-30
SU1731053A3 (ru) 1992-04-30
YU114987A (en) 1988-02-29
GB2179347A (en) 1987-03-04
FR2586681B1 (fr) 1991-02-22
HUT44775A (en) 1988-04-28
IT1197467B (it) 1988-11-30
KR880000179B1 (ko) 1988-03-12
IE862288L (en) 1987-02-28
YU147586A (en) 1988-02-29
FI92396B (fi) 1994-07-29
DE3530718C2 (es) 1992-07-09
MX9300436A (es) 1994-07-29
YU43998B (en) 1990-02-28
BE905340A (fr) 1987-02-27
CH673457A5 (es) 1990-03-15
GB2179347B (en) 1989-08-09
LU86556A1 (fr) 1986-12-02
SE465153B (sv) 1991-08-05
IE59239B1 (en) 1994-01-26
AR242568A1 (es) 1993-04-30
FR2586681A1 (fr) 1987-03-06
FI863282A0 (fi) 1986-08-13
NO863434D0 (no) 1986-08-27
DD266800A5 (de) 1989-04-12
PL148757B1 (en) 1989-11-30
YU44061B (en) 1990-02-28
NO863434L (no) 1987-03-02
HU895304D0 (en) 1990-03-28
DK407586D0 (da) 1986-08-27
SE8603589L (sv) 1987-03-01
JPS62167776A (ja) 1987-07-24
MX172917B (es) 1994-01-21
SE8603589D0 (sv) 1986-08-26
PL154026B1 (en) 1991-06-28
AT398568B (de) 1994-12-27
ZA866487B (en) 1987-04-29
JPH0349908B2 (es) 1991-07-31
PL268178A1 (en) 1988-10-13
IT8621526A0 (it) 1986-08-26
PT83258A (de) 1986-09-01
GB8619644D0 (en) 1986-09-24
KR870002119A (ko) 1987-03-30
DE3530718A1 (de) 1987-03-12
NL8602127A (nl) 1987-03-16
US5024743A (en) 1991-06-18
PL261196A1 (en) 1988-02-04
DK168705B1 (da) 1994-05-24

Similar Documents

Publication Publication Date Title
ES552432A0 (es) Procedimiento para preparar derivados de urea
ES557778A0 (es) Procedimiento para preparar derivados de isoxazol y furano.
ES550896A0 (es) Procedimiento para preparar espiro-dioxolanos-ditiolanos y oxotiolanos
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES556598A0 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbemicina
MX164766B (es) Procedimiento para la obtencion de derivados de cefem
ES557692A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES554112A0 (es) Procedimiento para preparar compuestos de ciclohexil y cicloexenil-imidazol
ES557389A0 (es) Procedimiento para preparar 1,2-dihidronaftalenos y derivados 1-oxa, 1-tia 1-sulfinilo y 1-sulfonilo de los mismos
ES557370A0 (es) Procedimiento para preparar derivados de (dihidro-4,5-1h-imidazolil-2)-dihidro-2,3-indol
MX3550A (es) Procedimiento para preparar derivados de metilendiocxifenantreno y estilbeno.
ES554371A0 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES555278A0 (es) Procedimiento para la obtencion de derivados de diclorociclopropilalquilhidroxialquil-azol
ES552000A0 (es) Procedimiento para preparar derivados de pirazol y bencimidazol.
ES552143A0 (es) Procedimiento para la obtencion de derivados de hexosa acilados
ES554828A0 (es) Procedimiento para preparar derivados de fluoralcanos.
MX162568A (es) Procedimiento para la preparacion de cloronitroanilinas y cloronitrofenoles
ES555036A0 (es) Procedimiento para preparar derivados de oxadiazolilimidazobenzodiazepina
ES550634A0 (es) Procedimiento para la obtencion de azacicloalcanos y azaci- cloalquenos 1,3,4-trisustituidos
ES557598A0 (es) Procedimiento para la obtencion de derivados de hexosa acilados
MX7073A (es) Derivados de piridinetanolamina y procedimiento para su preparacion
ES553140A0 (es) Procedimiento para preparar compuestos de imidazo-isoquinoleina y de imidazo-tienopiridina
MX3230A (es) Derivados de avermectina y procedimeiento para su preparacion.
MX13166A (es) Nuevos derivados de 2-anilino-pirimidina y procedimiento para su preparacion.
ES542696A0 (es) Procedimiento para la preparacion de derivados ecetilenicos y alenicos de 20aminometilindoles